RAFFA WEALTH MANAGEMENT, LLC’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.9K Buy
683
+279
+69% +$3.76K ﹤0.01% 430
2026
Q1
$5.59K Sell
404
-1
-0.2% -$14 ﹤0.01% 505
2025
Q4
$5.69K Hold
405
﹤0.01% 496
2025
Q3
$5.66K Buy
405
+165
+69% +$2.37K ﹤0.01% 462
2025
Q2
$3.61K Hold
240
﹤0.01% 562
2025
Q1
$3.17K Hold
240
﹤0.01% 526
2024
Q4
$3.79K Hold
240
﹤0.01% 508
2024
Q3
$3.81K Sell
240
-25
-9% -$402 ﹤0.01% 471
2024
Q2
$4.04K Buy
265
+30
+13% +$430 ﹤0.01% 577
2024
Q1
$3.45K Sell
235
-5
-2% -$73 ﹤0.01% 574
2023
Q4
$3.34K Buy
240
+40
+20% +$535 ﹤0.01% 477
2023
Q3
$2.67K Sell
200
-50
-20% -$676 ﹤0.01% 505
2023
Q2
$3.16K Buy
250
+120
+92% +$1.4K ﹤0.01% 481
2023
Q1
$1.48K Hold
130
﹤0.01% 689
2022
Q4
$1.35K Hold
130
﹤0.01% 694
2022
Q3
$1.36K Hold
130
﹤0.01% 703
2022
Q2
$1.44K Hold
130
﹤0.01% 697
2022
Q1
$1.45K Hold
130
﹤0.01% 731
2021
Q4
$1.7K Hold
130
﹤0.01% 702
2021
Q3
$1.69K Buy
130
+30
+30% +$400 ﹤0.01% 671
2021
Q2
$1.47K Hold
100
﹤0.01% 708
2021
Q1
$1.23K Buy
+100
New +$1.28K ﹤0.01% 772

Other funds holding RDY

RAFFA WEALTH MANAGEMENT, LLC's RDY Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its Dr. Reddy's Laboratories (RDY) stake by 69% in Q2 2026, buying an estimated $3.76K and bringing the position to 683 shares worth $9.9K. The position accounts for ﹤0.01% of the portfolio, ranked #430.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in RDY in Q1 2021 and has held it in 22 quarters since. 51 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 683 shares of Dr. Reddy's Laboratories worth $9.9K as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC bought 279 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $3.76K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #430 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Dr. Reddy's Laboratories in Q1 2021 and has held it in 22 quarters since.
  • 51 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.